07630

8.1007.06%
MG

Ming Guo

Co-Founder

Dr. Ming Guo, also known as Edward, is Co-Founder of Ascentage Pharma Group International in May 2009 and served as its President until October 31, 2021 and was its Chief Operating Officer since May 2009 until October 31, 2021. For positions with members of the Group, Dr. Guo is a director of Ascentage Shanghai and Ascentage International and general manager of Ascentage Jiangsu. Dr. Guo is Independent Non-Executive Director of IMPACT Therapeutics, Inc from May 2026. Dr. Guo has many years of industrial experience in research and development of new drug, regulatory, project management, corporate management, strategic planning and entrepreneurship. From 1995 to 2005, he served in various technical and managerial roles at Pfizer Inc. From March 2005 to 2010, he worked at Ascenta Therapeutics, Inc. as the vice president of pharmaceutical sciences and manufacturing. Dr. Guo served as an adjunct professor from 2007 to 2009 and served as a teaching staff as well a supervisor for master thesis since 2009 at Peking University. Dr. Guo served as the independent non-executive director at Porton Fine Chemicals Ltd. from October 2012 to March 2016. Dr. Guo was the recipient of “Special Contribution Award” from the China Food and Drug Administration in 2009. Dr. Guo obtained a Bachelor’s degree in Chemistry from Peking Normal University in January 1982. He received his Master’s degree in Medicine from Peking Union Medical College in June 1985 and his Ph.D. degree in Chemistry from the University of California at San Diego in the United States in March 1991.

Positions